Use of ibuprofen in paediatric populations

Journal of the Royal Society of Medicine, Supplement

Volumn 100, Issue 48, 2007, Pages 18-22

  Van Den Anker, John N ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; PARACETAMOL; PLACEBO;

ACUTE DISEASE; ANTIINFLAMMATORY ACTIVITY; BLOOD DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEVER; GASTROINTESTINAL HEMORRHAGE; HEMATOLOGIC DISEASE; HERPES ZOSTER; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LIVER TOXICITY; MUSCULOSKELETAL INJURY; PAIN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; SORE THROAT; UPPER RESPIRATORY TRACT INFECTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHICKENPOX; CHILD; FEVER; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES;

EID: 38849114509     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. World Health Organization. Pocket book of hospital care for children: Guidelines for the management of common illnesses with limited resources 2005. [http://www.who.int/child-adolescent-health/New_Publications/ CHILD_HEALTH/PB/00.PB_full.pdf] (accessed July 2007)
2. Porter JD, Robinson PH, Glasgow JF, Banks JH, Hall SM. Trends in the incidence of Reye's syndrome and the use of aspirin. Arch Dis Child 1990;65:826-9
3. Eccles R. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther 2006;31:309-19
4. Dlugosz CK, Chater RW, Engle JP. Appropriate use of nonprescription analgesics in pediatric patients. J Pediatr Health Care 2006;20:316-25; quiz 326-8
5. Schachtel BP, Thoden WR. A placebo-controlled model for assaying systemic analgesics in children. Clin Pharmacol Ther 1993;53:593-601
6. Clark E, Plint AC, Correll R, Gaboury I, Passi B. A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics 2007;119:460-7
7. Goldman RD, Ko K, Linett LJ, Scolnik D. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann Pharmacother 2004;38:146-150
8. Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis. Arch Pediatr Adolesc Med 2004;158:521-6
9. Purssell E. Treating fever in children: paracetamol or ibuprofen? Br J Community Nurs 2002;7:316-20
10. Autret E, Reboul-Marty J, Henry-Launois B, et. al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol 1997;51:367-71
11. Ulukol B, Koksal Y, Cin S. Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections. Eur J Clin Pharmacol 1999;55:615-8
12. McIntyre J, Hull D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. Arch Dis Child 1996;74:164-7
13. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995;273:929-33
14. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999;104:e39
15. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002;109:E20
16. EMEA. European Medicines Agency. European Public Assessment Report: Pedea, 2004. [http://www.emea.europa.eu/humandocs/Humans/EPAR/pedea/pedea. htm] (accessed July 2007)
17. Food and Drugs Agency. NDA 21-903; Approval letter: NeoProfen, 2006. [www.fda.gov/cder/foi/label/2006/021903lbl.pdf] (accessed July 2007)
18. Clyman RI. Ibuprofen and patent ductus arteriosus. NEJM 2000;343:728-30
19. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. NEJM 2000;343:674-81
20. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900
21. Cunningham MD, Ellison RC, Zierler S, Kanto WP, Jr., Miettinen OS, Nadas AS. Perinatal risk assessment for patent ductus arteriosus in premature infants. Obstet Gynecol 1986;68:41-5
22. Poon G. Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus. Proc Bayl Univ Med Cent 2007;20:83-5
23. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135-40
24. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36-42
25. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants (review). Cochrane Database of Syst Rev 2005;(4):CD003481
26. Kahn LH, Styrt BA. Necrotizing soft tissue infections reported with non-steroidal anti-inflammatory drugs. Ann Pharmacother 1997;31:1034-39
27. Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999;103:783-90
28. Lesko SM. The safety of ibuprofen suspension in children. Int J Clin Pract Suppl 2003;135:50-3
29. Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue super-infections in children with varicella. Ann Epidemiol 1997;7:440-5